Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Pathol Lab Med ; 145(5): 599-606, 2021 05 01.
Article in English | MEDLINE | ID: mdl-32960950

ABSTRACT

CONTEXT.­: Studies on the adoption of voice recognition in health care have mostly focused on turnaround time and error rate, with less attention paid to the impact on the efficiency of the providers. OBJECTIVE.­: To study the impact of voice recognition on the efficiency of grossing biopsy specimens. DESIGN.­: Timestamps corresponding to barcode scanning for biopsy specimen bottles and cassettes were retrieved from the pathology information system database. The time elapsed between scanning a specimen bottle and the corresponding first cassette was the length of time spent on the gross processing of that specimen and is designated as the specimen time. For the first specimen of a case, the specimen time additionally included the time spent on dictating the clinical information. Therefore, the specimen times were divided into the following 2 categories: first-specimen time and subsequent-specimen time. The impact of voice recognition on specimen times was studied using both univariate and multivariate analyses. RESULTS.­: Specimen complexity, prosector variability, length of clinical information text, and the number of biopsies the prosector grossed that day were the major determinants of specimen times. Adopting voice recognition had a negligible impact on specimen times. CONCLUSIONS.­: Adopting voice recognition in the gross room removes the need to hire transcriptionists without negatively impacting the efficiency of the prosectors, resulting in an overall cost saving. Using computer scripting to automatically enter clinical information (received through the electronic order interface) into report templates may potentially increase the grossing efficiency in the future.


Subject(s)
Pathology, Clinical/methods , Speech Recognition Software , Biopsy , Efficiency , Humans , Multivariate Analysis , Pathology, Clinical/organization & administration , Reproducibility of Results , Time Factors , Workflow
2.
Am J Surg Pathol ; 42(1): 130-136, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28877061

ABSTRACT

Mucoepidermoid carcinoma (MEC) is the most common salivary gland malignancy. Recent studies have shown that most MECs harbor gene fusions involving MAML2-an alteration that appears to be specific for MEC, a finding that could be diagnostically useful. While most cases of MEC are histologically straightforward, uncommon variants can cause considerable diagnostic difficulty. We present 2 variants of MEC for which MAML2 studies were crucial in establishing a diagnosis: a previously undescribed ciliated variant, and the recently described Warthin-like variant. All cases of ciliated and Warthin-like MEC were retrieved from the archives of The Johns Hopkins Hospital. Break-apart fluorescence in situ hybridization for MAML2 was performed on all cases. One ciliated MEC and 6 Warthin-like MECs were identified. The ciliated MEC presented as a 4.6 cm cystic lymph node metastasis originating from the tongue base in a 47-year-old woman. The Warthin-like MECs presented as parotid masses ranging in size from 1.2 to 3.3 (mean, 2.7 cm) in 4 women and 2 men. The ciliated MEC consisted of macrocystic spaces punctuated by tubulopapillary proliferations of squamoid cells and ciliated columnar cells. The Warthin-like MECs were comprised of cystic spaces lined by multilayered oncocytic to squamoid cells surrounded by a circumscribed cuff of lymphoid tissue with germinal centers. In these cases, the Warthin-like areas dominated the histologic picture. Conventional MEC, when present, represented a minor tumor component. MAML2 rearrangements were identified in all cases. Warthin-like MEC, and now a ciliated form of MEC, are newly described variants of a common salivary gland carcinoma. Unfamiliarity with these novel forms, unanticipated cellular features (eg, cilia), and morphologic overlap with mundane benign processes (eg, developmental ciliated cysts, Warthin tumor) or other carcinomas (eg, ciliated human papillomavirus-related carcinoma) may render these variants susceptible to misdiagnosis. These unusual variants appear to consistently harbor MAML2 fusions-a finding that establishes a clear link to conventional MEC and provides a valuable adjunct in establishing the diagnosis.


Subject(s)
Biomarkers, Tumor/genetics , Carcinoma, Mucoepidermoid/diagnosis , DNA-Binding Proteins/genetics , Gene Fusion , Gene Rearrangement , Nuclear Proteins/genetics , Salivary Gland Neoplasms/diagnosis , Transcription Factors/genetics , Adenolymphoma/pathology , Adult , Carcinoma, Mucoepidermoid/genetics , Carcinoma, Mucoepidermoid/pathology , Cilia/pathology , Female , Humans , Male , Middle Aged , Salivary Gland Neoplasms/genetics , Salivary Gland Neoplasms/pathology , Trans-Activators
3.
Diagn Cytopathol ; 45(12): 1132-1136, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28755513

ABSTRACT

Warthin-like mucoepidermoid carcinoma is a recently proposed variant of musoepidermoid carcinoma. Histologically, it is characterized by its close resemblance to Warthin tumor, including dense lymphocytic infiltration, flattened intermediate epithelium resembling squamous metaplasia, and cystic change. Given its histologic similarity to Warthin tumor, confirmatory testing for MAML2 rearrangement is often required for this diagnosis. Here we present the first cytologic reports of two 53-year-old female patients with parotid masses. In both cases, the fine needle aspirations showed fragments of bland epithelium with a squamous appearance, mucinous cyst content, and focal lymphocytic background. Neither frank keratinization nor mucinous cells were identified in the smears. Fluorescence in situ hybridization (FISH) study confirmed MAML2 rearrangement on the resection specimens in both. Other cytologic differential diagnoses, including Warthin tumor with metaplasia, lymphadenoma, and lymphoepithelial cyst, were briefly discussed.


Subject(s)
Adenolymphoma/pathology , Carcinoma, Mucoepidermoid/diagnosis , Carcinoma, Mucoepidermoid/pathology , Salivary Gland Neoplasms/diagnosis , Salivary Gland Neoplasms/pathology , Adenolymphoma/diagnosis , Biopsy, Fine-Needle/methods , Female , Humans , Middle Aged , Parotid Neoplasms/diagnosis , Parotid Neoplasms/pathology
4.
Am J Clin Pathol ; 134(2): 335-9, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20660340

ABSTRACT

Fine-needle aspiration (FNA) of thyroid bed (TB) lesions is a common diagnostic modality in monitoring patients for recurrent cancer after a thyroidectomy. To elucidate the value of TB FNA, we reviewed our experience at The Johns Hopkins Hospital, Baltimore, MD. We identified 57 TB FNA specimens from 50 patients. Of the patients, 36 were being followed up for papillary carcinoma, 7 for medullary carcinoma, 4 for follicular carcinoma (1 also had papillary carcinoma), and 1 for poorly differentiated neuroendocrine carcinoma; 3 had previous benign diagnoses. TB FNA yielded diagnostic material in 49 of 57 cases. Of 37 malignant or atypical FNA samples, 32 had surgical follow-up; 30 of 32 were confirmed malignant. The FNA result was benign in 12 of 57, including 6 cases of benign thyroid and 1 case of parathyroid tissue. Immunohistochemical staining was contributory in 5 of 57 cases. TB FNA is a highly reliable tool for diagnosing recurrent thyroid carcinoma. Residual benign thyroid and parathyroid tissue are potential pitfalls; awareness of these and judicious use of immunohistochemical staining can prevent misdiagnoses.


Subject(s)
Biopsy, Fine-Needle , Neoplasm Recurrence, Local/diagnosis , Thyroid Neoplasms/diagnosis , Humans , Neoplasm Recurrence, Local/surgery , Thyroid Neoplasms/surgery
5.
Am J Clin Pathol ; 133(5): 756-61, 2010 May.
Article in English | MEDLINE | ID: mdl-20395522

ABSTRACT

Small cell osteosarcoma may present a challenging primary diagnosis on cytologic assessment owing to its rarity and its morphologic similarity to other small round blue cell tumors. Five cases of small cell osteosarcoma from our cytopathology archives were identified and reviewed and cytologic features elaborated. Three cases were fine-needle aspirations from bony lesions in the classic location for osteosarcoma (2 distal femur and 1 proximal tibia), and 2 aspirations were from metastases. Common cytomorphologic features included relatively small to intermediate cell size, high nuclear/cytoplasmic ratios, round nuclei, minimal anisonucleosis, finely granular nuclear chromatin, fine cytoplasmic vacuoles, and only rare osteoid. Small cell osteosarcoma shares many of the well-described cytomorphologic features of classic osteosarcoma, but the relatively small cells, round hyperchromatic nuclei, and scant osteoid constitute the common denominator. Correlation with radiographic findings and ancillary tests can aid in definitive diagnosis.


Subject(s)
Bone Neoplasms/pathology , Osteosarcoma/secondary , Adolescent , Adult , Biopsy, Needle , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/therapy , Carcinoma, Small Cell/diagnosis , Cell Nucleus/pathology , Cell Size , Child , Combined Modality Therapy , Cytoplasm/pathology , Diagnosis, Differential , Humans , Male , Osteosarcoma/diagnostic imaging , Osteosarcoma/therapy , Radiography , Young Adult
7.
J Biol Chem ; 277(45): 43369-76, 2002 Nov 08.
Article in English | MEDLINE | ID: mdl-12213824

ABSTRACT

Cell cycle G(1) exit is a critical stage where cells commonly commit to proliferate or to differentiate, but the biochemical events that regulate the proliferation/differentiation (P/D) transition at G(1) exit are presently unclear. We previously showed that MAT1 (ménage à trois 1), an assembly factor and targeting subunit of the cyclin-dependent kinase (CDK)-activating kinase (CAK), modulates CAK activities to regulate G(1) exit. Here we find that the retinoid-induced G(1) arrest and differentiation activation of cultured human leukemic cells are associated with a switch to CAK hypophosphorylation of retinoic acid receptor alpha (RARalpha) from CAK hyperphosphorylation of RARalpha. The switch to CAK hypophosphorylation of RARalpha is accompanied by decreased MAT1 expression and MAT1 fragmentation that occurs in the differentiating cells through the all-trans-retinoic acid (ATRA)-mediated proteasome degradation pathway. Because HL60R cells that harbor a truncated ligand-dependent AF-2 domain of RARalpha do not demonstrate any changes in MAT1 levels or CAK phosphorylation of RARalpha following ATRA stimuli, these biochemical changes appear to be mediated directly through RARalpha. These studies indicate that significant changes in MAT1 levels and CAK activities on RARalpha phosphorylation accompany the ATRA-induced G(1) arrest and differentiation activation, which provide new insights to explore the inversely coordinated P/D transition at G(1) exit.


Subject(s)
Cell Cycle/physiology , Cell Differentiation/drug effects , Cyclin-Dependent Kinases/metabolism , Receptors, Retinoic Acid/physiology , Retinoids/pharmacology , Bone Neoplasms , Cell Cycle/drug effects , Cell Differentiation/physiology , Cell Line , G1 Phase , Humans , Jurkat Cells , Kidney , Leukemia , Osteosarcoma , Phosphorylation , Receptors, Retinoic Acid/drug effects , Retinoic Acid Receptor alpha , Tumor Cells, Cultured , Cyclin-Dependent Kinase-Activating Kinase
SELECTION OF CITATIONS
SEARCH DETAIL